PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Novartis to divest ophthalmology assets to Bausch + Lomb

Novartis has signed an agreement to divest its ‘front of eye’ ophthalmology assets to Bausch + Lomb, in a transaction valued up to $2.5 billion.

The deal, which involves an upfront payment of $1.75 billion, includes Xiidra, the first approved prescription treatment for the signs and symptoms of dry eye disease. Also included is investigational medicine SAF312, in development as a first-in-class therapy for chronic ocular surface pain, as well as the rights for use of the AcuStream delivery device in dry eye indications and OJL332, a second-generation TRPV1 antagonist in pre-clinical development.

Per its focused strategy unveiled last year, Novartis is looking to drive R&D productivity by prioritizing high-value medicines across five core therapeutic areas — cardiovascular, immunology, neuroscience, solid tumors and hematology.

On the ophthalmology front, Novartis says it will continue its R&D efforts in addressing retinal diseases via platforms including gene therapy and optogenetics.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026